RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells
Open Access
- 23 May 2010
- journal article
- Published by Springer Science and Business Media LLC in Journal of Experimental & Clinical Cancer Research
- Vol. 29 (1), 1-8
- https://doi.org/10.1186/1756-9966-29-53
Abstract
Background: MUC5AC is a secretory mucin normally expressed in the surface muconous cells of stomach and bronchial tract. It has been known that MUC5AC de novo expression occurred in the invasive ductal carcinoma and pancreatic intraepithelial neoplasm with no detectable expression in normal pancreas, however, its function remains uncertain. Here, we report the impact of MUC5AC on the adhesive and invasive ability of pancreatic cancer cells. Methods: We used two MUC5AC expressing cell lines derived from human pancreatic cancer, SW1990 and BxPC3. Small-interfering (si) RNA directed against MUC5AC were used to assess the effects of MUC5AC on invasion and adhesion of pancreas cancer cells in vitro and in vivo. We compared parental cells (SW1990 and BxPC3) with MUC5AC suppressed cells by si RNA (si-SW1990 and si-BxPC3). Results: MUC5AC was found to express in more than 80% of pancreatic ductal carcinoma specimens. Next we observed that both of si-SW1990 and si-BxPC3 showed significantly lower adhesion and invasion to extracellular matrix components compared with parental cell lines. Expression of genes associated with adhesion and invasion including several integerins, matrix metalloproteinase (MMP) -3 and vascular endothelial growth factor (VEGF) were down-regulated in both MUC5AC suppressed cells. Furthermore, production of VEGF and phosphorylation of VEGFR-1 were significantly reduced by MUC5AC down regulation. Both of si-SW1990 and si-BxPC3 attenuated activation of Erk1/2. In vivo, si-SW1990 did not establish subcutaneous tumor in nude mice. Conclusions: Knockdown of MUC5AC reduced the ability of pancreatic cancer cells to adhesion and invasion, suggesting that MUC5AC might contribute to the invasive motility of pancreatic cancer cells by enhancing the expression of integrins, MMP-3, VEGF and activating Erk pathway.Keywords
This publication has 36 references indexed in Scilit:
- Expression profiling of ETS and MMP factors in VEGF‐activated endothelial cells: Role of MMP‐10 in VEGF‐induced angiogenesisJournal of Cellular Physiology, 2010
- Integrin α9β1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinaseJournal of Cell Science, 2009
- Associations between Selected Biomarkers and Prognosis in a Population-Based Pancreatic Cancer Tissue MicroarrayCancer Research, 2009
- A Novel Transforming Growth Factor β Receptor Kinase Inhibitor, A-77, Prevents the Peritoneal Dissemination of Scirrhous Gastric CarcinomaClinical Cancer Research, 2008
- The Integrin-Extracellular Matrix Axis in Pancreatic CancerPancreas, 2007
- The Expression of MUC4 and MUC5AC Is Related to the Biologic Malignancy of Intraductal Papillary Mucinous Neoplasms of the PancreasPancreas, 2006
- RNA Interference Suppression of MUC1 Reduces the Growth Rate and Metastatic Phenotype of Human Pancreatic Cancer CellsClinical Cancer Research, 2006
- MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cellsJournal of Leukocyte Biology, 2004
- Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell LinesClinical Cancer Research, 2004
- Pancreatic cancer cell-derived vascular endothelial growth factor is biologically activein vitro and enhances tumorigenicityin vivoInternational Journal of Cancer, 2001